Welcome to our dedicated page for Nano-X Imaging news (Ticker: NNOX), a resource for investors and traders seeking the latest updates and insights on Nano-X Imaging stock.
NANO-X IMAGING LTD reports news on an integrated medical imaging and healthcare services platform built around Nanox.ARC multisource digital tomosynthesis systems, AI and software solutions, cloud-based workflow tools, remote radiology access, health information technology and a marketplace model. Company updates commonly cover U.S. commercialization, distribution agreements, clinical collaborations and regulatory clearances tied to Nanox.ARC and related imaging capabilities.
Recurring financial and operating news also includes results from teleradiology services, imaging products and services, AI and software activity, and the completed addition of Nanox Health IT. The company frames its commercial activity around broader access to 3D imaging and preventive-care workflows across clinical settings.
Nano X Imaging (NASDAQ: NNOX) said its U.S. unit Nanox Impact signed a distribution agreement with NuvioDx to support deployment of Nanox.ARC systems across clinical sites in multiple states. The Nanox.ARC is an FDA-cleared multisource digital tomosynthesis system that aims to enable 3D imaging at lower cost and reduced radiation dose versus traditional CT.
The deal expands Nanox’s 2026 U.S. distribution framework and channel partner strategy to broaden regional market access and sustained system utilization.
Nanox (NASDAQ:NNOX) announced that Nanox Impact signed a U.S. distribution agreement with Radiology Oncology Systems to roll out the Nanox.ARC across U.S. clinical settings. The Nanox.ARC is an FDA-cleared multisource digital tomosynthesis system intended to expand 3D imaging access with lower dose and cost.
The agreement leverages Radiology Oncology Systems’ distribution and service network to support planned deployments in oncology-adjacent and other clinical environments.
Nano-X Imaging (NASDAQ:NNOX) signed a commercial agreement with Howard Technology Solutions to deploy 300 Nanox.ARC systems over three years, including 60 systems in year one. The Nanox.ARC is an FDA-cleared multisource digital tomosynthesis system said to offer 3D imaging at lower cost and reduced radiation versus traditional CT.
Howard will market and deploy systems across its national healthcare and public sector channels, targeting underserved customer segments and leveraging its nationwide sales and service infrastructure.
NANO-X IMAGING (NASDAQ: NNOX) reported $3.7M revenue for Q4 2025 and a $33.4M net loss, driven largely by a $17.5M impairment tied to a South Korea manufacturing restructuring. The company closed the Nanox Health IT acquisition, signed U.S. distribution agreements (including 300 systems with Howard) and has ~36 systems in deployment.
Guy Nathanzon is appointed CFO effective August 1, 2026; restructuring charges total approximately $18.0M.
Nanox (Nasdaq: NNOX) announced on April 16, 2026 that its Nanox.ARC X 3D digital tomosynthesis system won the Red Dot Award: Product Design 2026. The award recognizes the system's compact, single-unit design, plug-and-play installation, and potential for broader clinical deployment. The device will be featured in Red Dot exhibitions and yearbook, increasing global visibility for the design created with TAGA Innovations.
The company emphasized the product's reduced footprint versus CT, simplified workflow, and remote upgrade capability as enablers for use in smaller imaging centers and outpatient clinics.
Nanox (Nasdaq: NNOX) announced a clinical collaboration with Meir Medical Center on April 14, 2026 to evaluate the Nanox.ARC multisource digital tomosynthesis system for emergency orthopedic imaging.
The IRB-approved study will compare Nanox.ARC to conventional radiography and CT for fracture detection, focusing on diagnostic confidence, speed, and lower radiation dose to support broader clinical adoption.
Nano X Imaging (NASDAQ: NNOX) announced that Nanox Impact signed a distribution agreement with Digital X-Ray Imaging to deploy the Nanox.ARC across DXI’s regional network in Arkansas. This marks Nanox’s fourth U.S. distribution collaboration in 2026 and aims to expand access to FDA-cleared digital tomosynthesis with local installation and service support.
DXI brings 30+ years of regional experience and a statewide team of factory-trained service engineers to support installations and ongoing clinical evaluations.
Nano-X Imaging (Nasdaq: NNOX) will report fourth quarter 2025 financial results before market open on Monday, April 20, 2026. A conference call and live webcast with CEO Erez Meltzer and CFO Ran Daniel begins at 8:30 a.m. ET to review results and provide a business update.
Registration and webcast links will be posted in the Investor Relations Events and Presentations section for interested parties.
Nanox (NASDAQ: NNOX) announced a U.S. distribution agreement with Integrity Medical Service to sell, implement and service the Nanox.ARC system across Colorado, Wyoming and western Kansas and Nebraska.
The agreement targets deployment of 4 systems in Year 1 and 12 systems in Year 2, and leverages Integrity’s field service engineers to support outpatient imaging adoption.
Nano-X Imaging (NASDAQ: NNOX) announced a U.S. distribution agreement with Elite Surgical Technologies to deploy the Nanox.ARC multisource digital tomosynthesis system across Ohio, Indiana, Michigan, Pittsburgh and West Virginia.
According to the company, the agreement targets orthopedic and post-surgical imaging, with a minimum of five systems in year one and ten in year two, subject to market conditions and customer adoption.